Zurich, Switzerland

Thomas Bark

USPTO Granted Patents = 6 

 

 

Average Co-Inventor Count = 15.0

ph-index = 1


Location History:

  • Zurich, CH (2016)
  • Zürich, CH (2016 - 2018)

Company Filing History:


Years Active: 2016-2018

Loading Chart...
Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: Innovative Contributions of Thomas Bark in Pharmaceutical Chemistry

Introduction

Thomas Bark, based in Zurich, CH, is a distinguished inventor with a remarkable portfolio of six patents. His work primarily focuses on the development of iron(III) complex compounds aimed at addressing iron deficiency symptoms and iron deficiency anemias. With a commitment to advancing pharmaceutical chemistry, Bark’s inventions offer valuable insights and solutions in the medical field.

Latest Patents

Thomas Bark's latest patents include innovative iron(III) complex compounds and pharmaceutical compositions designed for medicinal use. These inventions specifically target the treatment and prophylaxis of iron deficiency symptoms and iron deficiency anemias. By enhancing the efficacy of iron supplementation, Bark’s work demonstrates significant potential in improving patient outcomes.

Career Highlights

Currently, Thomas Bark is associated with Vifor (International) AG, a company recognized for its focus on iron deficiency solutions. His work there has significantly contributed to the advancement of pharmaceutical innovations, particularly in the area of iron therapies. Bark’s commitment to research and development in this critical health domain underscores his status as a leading figure in his industry.

Collaborations

Throughout his career, Thomas Bark has collaborated with notable coworkers, including Wilm Buhr and Susanna Burckhardt. These partnerships foster a dynamic exchange of ideas and expertise, driving the innovation process forward. Together, they contribute to enhancing the scientific understanding and practical applications of iron(III) complex compounds.

Conclusion

Thomas Bark's contributions to pharmaceutical chemistry through his inventive work with iron(III) complex compounds reflect a dedication to improving health outcomes for individuals suffering from iron deficiency. His innovative spirit and collaborative efforts with industry professionals position him as an influential inventor in this vital area of medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…